Dolby Laboratories, Inc. (DLB) Financial Statements
Dolby Laboratories, Inc. (DLB) reported trailing twelve-month revenue of $1.4B (up 0.6% year on year) and net income of $226.2M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $392.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DLBDolby Laboratories, Inc.Follow DLB — free
—
Price chart with a free account
- Market cap
- 5.9B
- P/E TTM
- 26.7
- Dividend yield
- 2.2%
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2010 Sep 10 | FY2011 Sep 11 | FY2012 Sep 12 | FY2013 Sep 13 | FY2014 Sep 14 | FY2015 Sep 15 | FY2016 Sep 16 | FY2017 Sep 17 | FY2018 Sep 18 | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.92 | 0.96 | 0.93 | 0.91 | 0.96 | 0.97 | 1.03 | 1.08 | 1.05 | 1.24 | 1.16 | 1.28 | 1.25 | 1.30 | 1.27 | 1.35 | 1.35 | |
| Gross profit | 0.79 | 0.85 | 0.84 | 0.81 | 0.89 | 0.88 | 0.92 | 0.96 | 0.93 | 1.08 | 1.02 | 1.15 | 1.11 | 1.15 | 1.13 | 1.19 | 1.19 | |
| Research & development | 0.10 | 0.12 | 0.14 | 0.17 | 0.18 | 0.20 | 0.22 | 0.23 | 0.24 | 0.24 | 0.24 | 0.25 | 0.26 | 0.27 | 0.26 | 0.26 | 0.27 | |
| Operating income | 0.43 | 0.43 | 0.36 | 0.25 | 0.27 | 0.21 | 0.23 | 0.25 | 0.18 | 0.26 | 0.22 | 0.34 | 0.21 | 0.22 | 0.26 | 0.26 | 0.24 | |
| Pre-tax income | 0.44 | 0.44 | 0.37 | 0.25 | 0.28 | 0.25 | 0.24 | 0.26 | 0.20 | 0.28 | 0.24 | 0.35 | 0.22 | 0.25 | 0.31 | 0.30 | 0.28 | |
| Income tax | 0.15 | 0.13 | 0.10 | 0.06 | 0.07 | 0.06 | 0.05 | 0.05 | 0.15 | 0.03 | 0.01 | 0.04 | 0.03 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Net income | 0.28 | 0.31 | 0.26 | 0.19 | 0.21 | 0.18 | 0.19 | 0.21 | 0.04 | 0.26 | 0.23 | 0.31 | 0.18 | 0.20 | 0.26 | 0.26 | 0.23 | |
| Diluted EPS ($) | 2.46 | 2.75 | 2.46 | 1.84 | 1.99 | 1.75 | 1.81 | 2.00 | 0.39 | 2.44 | 2.25 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 | 2.35 | |
| Diluted shares (bn) | 0.115 | 0.113 | 0.108 | 0.103 | 0.104 | 0.104 | 0.102 | 0.103 | 0.107 | 0.105 | 0.103 | 0.105 | 0.102 | 0.098 | 0.097 | 0.097 | — |
USD billions · SEC XBRL
Dolby Laboratories, Inc. — questions
- What is Dolby Laboratories, Inc.'s revenue?
- $1.4B over the twelve months to 2026-06-30, up 0.6% year on year, from its 10-Q and 10-K filings.
- What is Dolby Laboratories, Inc.'s net income?
- $226.2M over the twelve months to 2026-06-30.
- What is Dolby Laboratories, Inc.'s free cash flow?
- $392.7M over the twelve months to 2026-06-30.
- What are Dolby Laboratories, Inc.'s diluted earnings per share?
- $2.35 over the twelve months to 2026-06-30.
Every figure on this page comes from Dolby Laboratories, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.